- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/10 - 1,3,4-OxadiazolesHydrogenated 1,3,4-oxadiazoles
Patent holdings for IPC class C07D 271/10
Total number of patents in this class: 447
10-year publication summary
|
33
|
38
|
37
|
25
|
29
|
25
|
19
|
18
|
20
|
14
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chong Kun Dang Pharmaceutical Corp. | 235 |
24 |
| Denali Therapeutics Inc. | 246 |
10 |
| Merck Sharp & Dohme LLC | 3751 |
10 |
| Abbvie Inc. | 1800 |
9 |
| Modernatx, Inc. | 1257 |
9 |
| Reata Pharmaceuticals, Inc. | 123 |
9 |
| Calico Life Sciences LLC | 96 |
9 |
| Shionogi & Co., Ltd. | 852 |
8 |
| Takeda Pharmaceutical Company Limited | 2708 |
7 |
| Novartis AG | 10744 |
6 |
| AstraZeneca AB | 2892 |
6 |
| Merck Patent GmbH | 5815 |
6 |
| SK Biopharmaceuticals Co., Ltd. | 262 |
6 |
| Ikena Oncology, Inc. | 59 |
6 |
| Bayer Cropscience AG | 2040 |
5 |
| Boehringer Ingelheim International GmbH | 4642 |
4 |
| Janssen Pharmaceutica N.V. | 3394 |
4 |
| Allergan, Inc. | 2347 |
4 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2165 |
4 |
| Canopy Growth Corporation | 220 |
4 |
| Other owners | 297 |